Saturday, November 2, 2024
HomeIndustriesBiotechnology

Biotechnology

VitalConnect Secures over $30 Million in Oversubscribed Series F Financing

VitalConnect, Inc., a leader in remote and in-hospital wearable biosensor technology, announced closing on an oversubscribed Series F financing in excess of $30 million....

Illumina DRAGEN™ 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery

Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of the latest version of DRAGEN™ software for analysis of...

Himed and Lithoz Enter Medical 3D Printing Materials Research Partnership

Advancing 3D-printed medical implants depends on the steady progress of leading-edge printer technologies, as well as the skillful development of the raw materials used...

nirvanaHealth’s Payer & PBM business suite, Aria will go live during open enrollment this year and launch on Microsoft Azure Marketplace

nirvanaHealth announces that Aria, the Payer & PBM business suite that will empower Payers & PBMs to design their own business solutions, will be...

Datopotamab Deruxtecan Met Dual Primary Endpoint of Progression-Free Survival in Patients With Advanced Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
0FansLike
0FollowersFollow
spot_img

Hot Topics